References
Kleinz, M.J. and Davenport, A.P., Pharmacol. Ther., 2005, vol. 107, pp. 198–211.
Simpkin, J.C., Yellon, D.M., Davidson, S.M., et al., Basic Res. Cardiol., 2007, vol. 102, pp. 518–528.
Pisarenko, O.I., Serebryakova, L.I., Pelogeikina, Yu.A., et al., Byull. Eksp. Biol. Med., 2011, vol. 152, no. 7, pp. 86–89.
Rastaldo, R., Cappello, S., Folino, A., et al., Antioxid. Redox Signal., 2011, vol. 14, pp. 909–921.
Smith, C.C., Mocanu, M.M., Bowen, J., et al., Cardiovasc. Drugs Ther., 2007, vol. 21, pp. 409–414.
Langelaan, D.N. and Rainey, J.K., J. Phys. Chem., 2009, vol. 113, pp. 10 465–10 471.
Pisarenko, O.I., Shul’zhenko, V.S., Pelogeykina, Yu.A., et al., Kardiologiya, 2010, vol. 50, no. 10, pp. 44–49.
Vickers, C., Hales, P., Kaushik, V., et al., J. Biol. Chem., 2002, vol. 277, pp. 14 838–14 843.
Synthetic Peptides: A User’s Guide, Grant, G.A., Ed., Oxford: Oxford Univ. Press, 2002, 2nd edition.
Messari, S.E., Iturrioz, X., Fassot, C., et al., J. Neurochem., 2004, vol. 90, pp. 1290–1301.
Lee, D.K., Saldivia, V.R., Nguyen, T., et al., Endocrinology, 2005, vol. 146, pp. 231–236.
Pisarenko, O.I., Serebryakova, L.I., Pelogeykina, Yu.A., et al., Kardiologiya, 2012, vol. 52, no. 2, pp. 63–69.
Rastaldo, R., Cappello, S., Folino, A., et al., Am. J. Physiol. Heart Circ. Physiol., 2011, vol. 300, pp. H2308–H2315.
Author information
Authors and Affiliations
Additional information
Original Russian Text © O.I. Pisarenko, Yu.A. Pelogeykina, Zh.D. Bespalova, L.I. Serebryakova, M.V. Sidorova, A.A. Az’muko, D.N. Khatri, I.M. Studneva, M.E. Pal’keeva, O.V. Tskitishvili, A.S. Molokoedov, 2012, published in Doklady Akademii Nauk, 2012, Vol. 443, No. 1, pp. 127–129.
Rights and permissions
About this article
Cite this article
Pisarenko, O.I., Pelogeykina, Y.A., Bespalova, Z.D. et al. Limitation of myocardial infarction by a structural analog of the peptide apelin-12. Dokl Biol Sci 443, 65–67 (2012). https://doi.org/10.1134/S0012496612020044
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0012496612020044